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Strain ratioAbstract Objective: To detect the impact of ultrasound elastography in diagnosis of prostatic
cancer, and to evaluate its capability in differentiating benign from malignant lesions.
Materials and methods: Fifty patients with different prostatic lesions suspicious for malignancy
were included. All patients had a conventional B-mode ultrasound examination and color
Doppler imaging, and then real time ultrasound elastography was performed in the same session.
Finally, the results were compared to the histo-pathological results of those lesions.
Results: The addition of Strain ratio parameter for evaluating the elastography images showed the
highest sensitivity of 74.2%, speciﬁcity of 73.7% and accuracy of 74.0% at a best cutoff point of 5.5
between benign and malignant lesions.
Conclusion: Based on our results, prostate US combined with elastography can be a helpful tool
for ﬁnding malignant lesions. Also it can help in targeting the biopsy site.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Prostate cancer is the 2nd most common cancer worldwide for
males, and the 5th most common cancer overall (1). Because
there is no effective way of detecting prostate cancer withcurrent imaging techniques, systematic ultrasound-guided
biopsy is used to detect prostate cancer in patients with ele-
vated prostate speciﬁc antigen (PSA) levels. However, sam-
pling errors are common, and many patients have to repeat
biopsies before cancer is detected (2). Ultrasound elastography
was developed in the early nineties as an alternative ultrasono-
graphic technique able to visualize tissue stiffness (3). Prostate
carcinoma is signiﬁcantly stiffer than normal prostate tissue.
Using sonoelastography to target biopsy sites has the potential
to allow prostate cancer detection with fewer biopsy cores than
systematic biopsy (4). The principle of elastography is that tis-
sue compression produces strain (displacement) within the tis-
sue and that the strain is smaller in harder tissue than in softer
Fig. 1 Sonoelastographic scoring system proposed by Kamoi
et al.: (a) score 1 – normal – homogeneous strain, the entire gland
evenly shaded in green; (b) score 2 – probably normal – symmetric
heterogeneous strain, the gland shows a symmetrical mosaic
pattern of green and blue; (c) score 3 – indeterminate – focal
asymmetric stiff lesion not related to hypoechoic area, the focal
asymmetric lesion in blue, in the left lobe; (d) score 4 – probably
carcinoma – hypoechoic lesion (bulging the contour of the left
lobe, arrowheads) with stiffness in the center of the lesion and
strain at the periphery; the peripheral part of lesion in green and
the central part in blue; (e) score 5 – deﬁnitely carcinoma –
stiffness in the entire hypoechoic lesion in the right lobe and in the
surrounding area, the entire lesion in blue.
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compression, we can estimate tissue hardness (5). In order to
assess the Elastographic appearance of the prostate, Kamoi
et al. proposed a subjective scoring system that takes into
account both the grayscale appearance and the stiffness dis-
played by elastography. The key point in this scale is repre-
sented by the relationship between a hypoechoic lesion and a
stiff prostatic area. Lesions scaled 3 and above are highly sug-
gestive of malignancy (6). Strain ratio measurement is obtained
by dividing the mean strain within the normal prostatic tissue
by the mean strain from the lesion (7).
2. Patients and methods
2.1. Study population
2.1.1. Inclusion criteria
 The study was prospectively carried on 50 male patients
with prostatic lesions (between June 2013 and February
2015). Male patients with abnormal digital rectal examina-
tion of the prostate and/ or value of PSA > 4 ng/ml were
included in the study after obtaining informed consent.
The study is IBR approved.
2.1.2. Exclusion criteria
 Patients with anal complications or rectal mass.
 Patients subjected to prostatic adenomectomy (TURP or
open adenomectomy).
 Patients refusing the examination.
 Patients with bleeding tendency.
2.2. Equipment
 The study was performed on a digital ultrasound scanner
(EUB-7500; Hitachi medical, Tokyo, Japan) with real time
tissue elastography unit EZU-TE3, by placing a high fre-
quency (7.5 MHz) endorectal end-ﬁre transducer in close
proximity to the prostate.
2.3. Techniques
 First, prostatic lesions were evaluated by conventional B-
mode ultrasound and color Doppler imaging. On the
same session, real time US elastography examination
was performed. The probe was applied to the prostate
and was compressed and retracted at a ﬁxed speed in
a direction perpendicular to the diagnosis area. The
probe was applied with light pressure and used the
‘‘press indicator’’, which is a column of numbers dis-
played on the side of the image that shows the current
amount of compression with the probe, as a guide.
Lesions were biopsied by using US guided interventional
procedures by true cut needle biopsy (via 22-gauge
spinal needle). Imaging ﬁndings were correlated with sex-
tant prostate biopsies and targeted biopsies on suspicious
areas.3. Elastography analysis
 We chose a color map in which red and green indicate softer
areas, while blue indicate harder areas. We set the Region of
Fig. 2 (a) Transrectal ultrasound B-mode image shows multiple hypoechoic focal lesions in a 62-year-old male presented with prostatic
enlargement symptoms, elevated PSA level (30.5 ng/mL) with enlarged hard prostate consistency by PR examination. (b) In color Doppler
they appear hypovascular.
Fig. 3 The strain ratio (SR) calculation in the focal lesion (A) in relation to normal prostatic tissue (B). SR = B/A was 17.25 in this case
indicating malignancy. By elastography, the scoring was 4 (strain at the periphery of the hypoechoic lesions with sparing of the center of
the lesion, the peripheral part of lesion is green and the central part is blue, so mostly malignant). TRUS guided biopsy was done revealed
prostatic Adenocarcinoma (Gleason Score 4+ 4).
Fig. 4 (a) Transrectal ultrasound B-mode image shows the loss of normal architecture of the peripheral zone with an ill deﬁned
hypoechoic focal lesion in a 68-year-old male presented with prostatic enlargement symptoms, elevated PSA level (35 ng/mL) with
enlarged hard prostate consistency by PR examination. (b) In color Doppler, it appears hypervascular.
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Fig. 5 The strain ratio (SR) calculation in the focal lesion (A) in relation to normal prostatic tissue (B). SR = B/A was 0.9 in this case
indicating benign nature. By elastography, the scoring was 3(indeterminate – focal asymmetric stiff lesion not related to hypoechoic area,
the focal asymmetric lesion is blue, in the left lobe). TRUS guided biopsy was done revealed well differentiated Adenocarcinoma, Gleason
Score 7 (3+ 4).
Fig. 6 (a) Transrectal ultrasound B-mode image shows irregular hypoechoic focal lesion in the right lobe of the peripheral zone causing
focal capsular bulge in a 72-year-old male presented with prostatic enlargement symptoms, elevated PSA level (21.8 ng/mL) with enlarged
hard prostate consistency by PR examination. (b) In color Doppler it appears hypovascular.
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surrounding the lesion. In the qualitative (color coded) eval-
uation of the sonoelastographic images, lesion classiﬁcation
was performed on the basis of a 5-point scoring method
(Fig. 1). Score 1: Homogeneous strain, the entire gland
evenly shaded in green. Score 2: Symmetric heterogeneous
strain, the gland shows a symmetrical mosaic pattern of
green and blue. Score 3: Focal asymmetric lesion without
strain, not related to hypoechoic lesion, the focal asymmet-
ric lesion in blue. Score 4: Strain at the periphery of the
hypoechoic lesion with sparing of the center of the lesion,
the peripheral part of lesion in green and the central part
in blue. Score 5: No strain in the entire hypoechoic lesion
or in the surrounding area, the entire lesion in blue. Then
the strain ratios of the lesions were calculated (Figs. 2–7).4. Results
This study was prospectively carried on 50 patients, the mean
age for all patients was 63.1 years (age range, 50–79 years), 19
patients with benign lesions had a mean age of 60.4 years (age
range, 54–70 years), and 31 patients with malignant lesions
had a mean age of 64.7 years (age range, 50–79 years). The
median of the total PSA level for all patients was
31.8 ng/mL (range, 7.5–130 ng/mL). The median for prostatic
volume was 63.0 mL (range, 43–145 mL). Conventional B-
mode ultrasound examination and real-time ultrasound elas-
tography were performed, 8 (16%) patients were categorized
as Elastoscoring 2, 14 (28%) patients were categorized as
Elastoscoring 3, 19 (38%) patients were categorized as
Elastoscoring 4, and 9 (18%) patients were categorized as
Fig. 7 The strain ratio (SR) calculation in the focal lesion (A) in relation to normal prostatic tissue (B). SR = B/A was 35 in this case
indicating malignancy. By elastography, the scoring was 4 (strain at the periphery of the hypoechoic lesion with sparing of the center of the
lesion, the peripheral part of lesion is green and the central part is blue, so mostly carcinoma). TRUS guided biopsy was done revealed
Adenocarcinoma, Gleason Score 9 (4+ 5).
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According to elastography results, 28 out of 50 patients
(56%) had prostatic cancer and 22 out of 50 patients (44%)
had benign lesions. The ﬁnal pathological diagnoses in our
study revealed 31 out of 50 patients (62%) were positive for
prostate carcinoma and 19 out of 50 patients (38%) were neg-
ative for prostate carcinoma. The pathological score forTable 1 Description of different parameters.
Description (n= 50)
Age range, mean ± SD 50–79 63.1 ± 7.6
Median, IQR 62.5 56.8–68.3
Elastography scoring n (%)
2 8 16.0
3 14 28.0
4 19 38.0
5 9 18.0
Elastography results n (%)
Malignant 28 56.0
Non-malignant 22 44.0
Pathology n (%)
Malignant 31 62.0
Non-Malignant 19 38.0
Pathology score (n = 31) n (%)
2 + 2 9 29.0
2 + 3 3 9.7
3 + 3 2 6.5
3 + 4 6 19.4
4 + 4 8 25.8
4 + 5 2 6.5
5 + 5 1 3.2
Prostatic volume range, mean ± SD 43–145 75.2 ± 27.2
Median, IQR 63.0 57.8–91.8
PSA level range, mean ± SD 7.5–130 43.2 ± 36.5
Median, IQR 31.8 10.0–74.0
Strain ratio range, mean ± SD 0.49–50 16.0 ± 15.6
Median, IQR 9.5 3.3–30.4
SD= standard deviation, IQR interquartile range.prostate cancer patients in our study revealed 9 patients out
of 31 (29%) with Gleason score 2 + 2, 3 patients with
Gleason score 2 + 3 (9.7%), 2 patients with Gleason score
3 + 3 (6.5%), 6 patients with Gleason score 3 + 4 (19.4%),
8 patients with Gleason score 4 + 4 (25.8%), 2 patients with
Gleason score 4 + 5 (6.5%), and 1 patient with Gleason score
5 + 5 (3.2%). For statistical analysis we considered
Elastoscoring categories of 1, 2, 3 as benign and that of 4
and 5 as malignant. On performing this, there were 14 cases
out of 19 (73.7%) cases were benign (true negative) by sonoe-
lastography compared to the pathology, and 23 cases out of 31
(74.2%) cases were malignant by sonoelastography compared
to the pathology (true positive), 5 cases out of 19 (26.3%)
are false positive, and 8 cases out of 31 are false negative
(25.8%) as shown in Table 1. The prostate is divided into
sex areas as follow: peripheral median, intra-adenomatous,
peripheral right, peripheral left, apex and anterior. Each area
is evaluated by elastography, and 300 systematic cores were
taken in addition to 100 cores from suspicious areas.
Evaluation of sensitivity, speciﬁcity, PPV, NPV and accuracyTable 2 Percentage distribution of different anatomical pro-
static zones among the proved prostatic cancer patients, total
cases and total biopsy cores.
Cores N % out of total
malignant
(n= 31) (%)
% out of total
cases (n= 50)
(%)
% out of total
cores (n= 300)
(%)
Peripheral
right
6 19.4 12.0 2.0
Peripheral
left
5 16.1 10.0 1.7
Peripheral
median
9 29.0 18.0 3.0
Apex 3 9.7 6.0 1.0
Intra-
adenomatous
7 22.6 14.0 2.3
Anterior 1 3.2 2.0 0.3
Table 3 Sensitivity, Speciﬁcity, PPV, NPV and Accuracy of elastography at each core separately and for targeted cores from
suspicious areas.
Sensitivity (%) Speciﬁcity PPV (%) NPV (%) Accuracy (%)
Peripheral right 100.0 50.0 21.4 100.0 56.0
Peripheral left 60.0 44.4 10.7 90.9 46.0
Peripheral median 88.9 51.2 28.6 95.5 58.0
Apex 33.3 42.6 3.6 90.9 42.0
Intra-adenomatous 57.1 44.2 14.3 86.4 46.0
Anterior 100.0 44.9 3.6 100.0 46.0
Sum of cores 74.2 46.1 13.7 93.9 49.0
Targeted cores 86.4 87.8 91.1 81.8 87.0
Table 4 Comparison of pathology result regarding different
parameters.
Pathology P value
Malignant
(n= 31)
Non-Malignant
(n= 19)
Elastography results n (%)
Malignant 23, 74.2% 5, 26.3% 0.001
Non-Malignant 8, 25.8% 14, 73.7%
Age
Range 50.0–79.0 54.0–70.0 0.053
Mean ± SD 64.7 ± 8.4 60.4 ± 5.0 NS
Median 64.0 60.0
Prostatic volume
Range 43.0–145.0 52.0–80.0 0.003
Mean ± SD 84.2 ± 31.0 60.4 ± 7.2 S
Median 67.0 58.5
PSA level
Range 12.0–130.0 7.5–14.0 <0.001
Mean ± SD 63.7 ± 32.1 9.8 ± 1.8 S
Median 63.5 9.5
Strain ratio
Range 0.9–50.0 0.5–19.0 <0.001
Mean ± SD 22.4 ± 16.3 5.5 ± 5.6 S
Median 21.0 3.3
Mann Whitney test.
Table 5 Comparison of elastography result regarding differ-
ent parameters.
Elastography results P value
Malignant
(n= 28)
Non-Malignant
(n= 22)
Age
Range 55.0–79.0 50.0–70.0 0.002
Mean ± SD 66.1 ± 7.5 59.2 ± 5.8 S
Median 64.5 59.0
Prostatic volume
Range 43.0–103.0 52.0–145.0 0.891
Mean ± SD 68.7 ± 15.9 83.4 ± 35.7 NS
Median 64.0 60.0
PSA level
Range 9.0–130.0 7.5–102.0 0.062
Mean ± SD 47.8 ± 34.8 37.3 ± 38.5 NS
Median 40.5 10.5
Mann Whitney test.
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cores from suspicious areas as shown in Tables 2 and 3.
The malignancy detected by elastography was signiﬁcantly
associated with true malignancy in the pathology results. The
mean age for malignant lesions was slightly higher than that
for benign lesions and this difference was statistically insignif-
icant (P value 0.053). It was found that the median PSA level
for malignant lesions was 63.5 ng/mL and 9.5 ng/mL for non-
malignant lesions. This difference was statistically signiﬁcant
(P value <0.001). It was found that the median prostatic vol-
ume for malignant lesions was 67 mL and 58.5 mL for non-
malignant lesions .This difference was statistically signiﬁcant
(P value 0.003). It was found that the median strain ratio
was 21.0 for malignant lesions and 3.3 for non-malignant
lesions, and this difference was statistically signiﬁcant(P value < 0.001) as shown in Table 4. According to elastog-
raphy results, there was a signiﬁcant difference between malig-
nant and non-malignant lesions regarding age while there was
no signiﬁcant difference between malignant and non-
malignant lesions regarding prostatic volume and PSA level
as shown in Table 5. Strain ratio showed signiﬁcant propor-
tionate strong correlation with pathological Gleason score. It
also showed signiﬁcant proportionate moderate correlation
with age and PSA level while no signiﬁcant correlation
between the strain ratio and prostatic volume as shown in
Table 6. Roc curve analysis revealed that strain ratio was a sig-
niﬁcant discriminant factor in predicting prostate malignancy
(P value < 0.001) with area under curve (AUC) 0.828 and
95% conﬁdence interval (0.717 – 0.938). Screening analysis
of elastography in the prediction of malignancy using strain
ratio revealed, the most accurate cutoff point of strain ratio
as presented by ROC curve analysis wasP 5.5 with sensitivity
74.2%, Speciﬁcity 73.7%, PPV 82.1%, NPV 63.6% and accu-
racy 74.0% as shown in Tables 7 and 8.
5. Discussion
False results, both positive and negative, may occur during
sonoelastography for prostate cancer, with a sizeable inﬂuence
Table 6 Correlation of strain ratio with other parameters.
Strain ratio
r P value
Age 0.459 0.001
S
Prostatic volume 0.011 0.939
NS
PSA level 0.409 0.003
S
Pathology score 0.872 <0.001
S
r= Spearman correlation coefﬁcient, NS = non-signiﬁcant,
S = signiﬁcant.
ROC curve analysis to explore the discriminant ability of strain
ratio in predicting malignancy.
Table 7 ROC curve analysis revealed that SR was a signif-
icant discriminant factor in predicting prostate malignancy (P
value <0.001) with AUC 0.828 and 95% conﬁdence interval
(0.717–0.938).
Tested variable AUC 95% CI P value
Strain ratio 0.828 0.717–0.938 <0.001
Table 8 The most accurate cutoff point of strain ratio as
presented by ROC curve analysis wasP 5.5 with sensitivity
74.2%, Speciﬁcity 73.7%, PPV 82.1%, NPV 63.6% and
accuracy 74.0%.
Tested
variable
Cutoﬀ
point
Sensitivity
(%)
Speciﬁcity
(%)
PPV
(%)
NPV
(%)
Accuracy
(%)
Strain
ratio
P5.5 74.2 73.7 82.1 63.6 74.0
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or a large transitional zone places part of the prostate out of
the range of sonoelastography. Large calciﬁcation in the
peripheral gland as a consequence of prostatitis induces hard
areas in the parenchyma. Multifocal tumors with individualfocus diameter less than 3–5 mm are difﬁcult to depict. Very
large tumors, involving the whole gland, do not produce focal
stiff areas. On the other hand, positive elastography with neg-
ative biopsy has been reported in the benign hypertrophy
patients (9). The majority of false positive results are associ-
ated with chronic inﬂammation and atrophy in the basal area
of the gland (10). The main limitations of the method are
related to the variability induced by manual operation of the
probe and examiner experience. The effect of these limitations
may be reduced by using automated balloon pulsation and ver-
ifying the accuracy of vibration on the automated scale (11). In
our study, screening analysis of elastography in prediction of
malignancy using pathology as a gold standard revealed, the
most accurate cutoff point of strain ratio as presented by
ROC curve analysis was P5.5 with sensitivity 74.2%,
Speciﬁcity 73.7%, PPV 82.1%, NPV 63.6% and accuracy
74.0%. The study done by Salomon et al. (12) reported sensi-
tivity (75.4%), speciﬁcity (76.6%), PPV (87.8%), NPV (59%),
and accuracy (76%) and the study done Barr et al. (13)
reported sensitivity of 100%, speciﬁcity of 95.6%, PPV of
75%, and NPV of 100%. In our study, we found that the strain
ratio of 5.5 as the cutoff point, between malignant and benign
lesions could be identiﬁed accurately which is close to the cut-
off point 3.05 in the previous study done by Zhai et al. (14) and
far away from the cutoff point 17.44 in the study done by
Zhang et al. (15). In our study we found also that the strain
ratio had signiﬁcant proportionate strong correlation with
the pathological Gleason score. The studies done by Sumura
et al. (16) and Zhang et al. (15) reported the strong relationship
between the Gleason scores and the elastographic ﬁndings.
6. Conclusion
Based on our results, prostate US elastography can be a help-
ful tool for ﬁnding malignant lesions. Also it can help in target-
ing the biopsy site; however, better evaluation by bigger study
is advised.
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